Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 USD | +27.45% | +30.00% | +220.20% |
Valuation
Fiscal Period: March | 2022 | 2023 |
---|---|---|
Capitalization 1 | 117.6 | 65.94 |
Enterprise Value (EV) 1 | 119.1 | 67.7 |
P/E ratio | -103 x | -29.5 x |
Yield | - | - |
Capitalization / Revenue | 50.5 x | 39.7 x |
EV / Revenue | 51.2 x | 40.7 x |
EV / EBITDA | -106 x | -54.2 x |
EV / FCF | 22,987 x | 86.4 x |
FCF Yield | 0% | 1.16% |
Price to Book | 125 x | -190 x |
Nbr of stocks (in thousands) | 17,547 | 17,680 |
Reference price 2 | 6.700 | 3.730 |
Announcement Date | 26/09/22 | 27/07/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.2595 | 1.218 | 1.22 | 1.624 | 2.329 | 1.663 |
EBITDA 1 | -0.3977 | 0.3181 | -0.0792 | -0.008605 | -1.124 | -1.249 |
EBIT 1 | -0.0456 | 0.3121 | -0.0855 | -0.0146 | -1.129 | -1.253 |
Operating Margin | -17.58% | 25.64% | -7.01% | -0.9% | -48.49% | -75.39% |
Earnings before Tax (EBT) 1 | -0.0456 | 0.2961 | -0.0873 | -0.0274 | -1.114 | -1.759 |
Net income 1 | -0.0456 | 0.2802 | -0.0873 | -0.028 | -1.126 | -2.231 |
Net margin | -17.58% | 23.01% | -7.16% | -1.73% | -48.34% | -134.19% |
EPS 2 | -0.0537 | 0.0165 | -0.005231 | -0.001634 | -0.0651 | -0.1263 |
Free Cash Flow 1 | -0.0207 | 0.2451 | -0.1374 | -0.4391 | 0.005182 | 0.7839 |
FCF margin | -7.97% | 20.13% | -11.27% | -27.03% | 0.22% | 47.15% |
FCF Conversion (EBITDA) | - | 77.06% | - | - | - | - |
FCF Conversion (Net income) | - | 87.47% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 28/04/20 | 05/09/19 | 17/08/20 | 16/08/21 | 26/09/22 | 27/07/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.05 | - | 0.66 | 1.5 | 1.55 | 1.76 |
Net Cash position 1 | - | 0.14 | - | - | - | - |
Leverage (Debt/EBITDA) | -0.1265 x | - | -8.372 x | -174.9 x | -1.382 x | -1.406 x |
Free Cash Flow 1 | -0.02 | 0.25 | -0.14 | -0.44 | 0.01 | 0.78 |
ROE (net income / shareholders' equity) | 92.4% | 21.4% | -5.96% | -1.88% | -92.2% | -573% |
ROA (Net income/ Total Assets) | -28,515% | 11.4% | -2.57% | -0.32% | -22.4% | -30.5% |
Assets 1 | 0.00016 | 2.466 | 3.394 | 8.812 | 5.032 | 7.309 |
Book Value Per Share 2 | -0.0800 | 0.0900 | 0.0900 | 0.0900 | 0.0500 | -0.0200 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0.0100 | 0.0100 | 0.0200 |
Capex | - | - | 0.01 | 0.01 | - | 0.02 |
Capex / Sales | - | - | 0.62% | 0.35% | - | 1.35% |
Announcement Date | 28/04/20 | 05/09/19 | 17/08/20 | 16/08/21 | 26/09/22 | 27/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+220.20% | 115M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- ZHYBF Stock
- Financials Zhong Yuan Bio-Technology Holdings Limited